Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Colorcon
Mallinckrodt
Express Scripts
McKinsey

Last Updated: September 26, 2022

Details for New Drug Application (NDA): 020226


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


NDA 020226 describes NAPHCON-A, which is a drug marketed by Alcon and is included in one NDA. It is available from two suppliers. Additional details are available on the NAPHCON-A profile page.

The generic ingredient in NAPHCON-A is naphazoline hydrochloride; pheniramine maleate. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.
Summary for 020226
Tradename:NAPHCON-A
Applicant:Alcon
Ingredient:naphazoline hydrochloride; pheniramine maleate
Patents:0
Suppliers and Packaging for NDA: 020226
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NAPHCON-A naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 020226 NDA Alcon Laboratories, Inc. 0065-0085 0065-0085-15 1 BOTTLE in 1 CARTON (0065-0085-15) > 15 mL in 1 BOTTLE
NAPHCON-A naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 020226 NDA Alcon Laboratories, Inc. 0065-0085 0065-0085-42 2 BOTTLE in 1 CARTON (0065-0085-42) > 5 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION/DROPS;OPHTHALMICStrength0.025%;0.3%
Approval Date:Jun 8, 1994TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Baxter
McKesson
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.